The involvement of anti-LAMP2 autoantibodies remains controversial in crescentic glomerulonephritis because of the absence of confirmatory data from other groups regarding their high prevalence and their pathogenicity (Kettritz 2012; Roth et al. 2012). This evidence concerns the gene LAMP2 and crescentic glomerulonephritis.